Lunai Bioworks Inc. — Director's Dealing 2022

Mar 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enochian Biosciences Inc (ENOB)
CIK: 0001527728
Period of Report: 2022-03-22

Reporting Person: Sandler Carl Forest (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-22	Common Stock	S	1927	$9.06	Disposed	3187487	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	269344	Indirect
Common Stock	4961363	Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2021.

F2: Mr. Sandler is a member and a manager of Weird Science and has shared voting and disposition power of the shares owned by Weird Science, LLC.